References
American Health Care Association. 2015. Skilled Nursing Care Centers Fast Facts. Washington, DC: American Health Care Association.
Anderson, A. S. 2022. A lightspeed approach to pandemic drug development. Nature Medicine 28(8):1538. https://doi.org/10.1038/s41591-022-01945-6.
Assistant Secretary for Preparedness and Response. 2022. BARDA Strategic Plan: 2022-2026. Washington, DC: ASPR.
Barsade, S., J. Chatman, A. Duckworth, J. Barsade, A. Buttenheim, G. Chapman, R. Dialdini, L. Dhanini, B. Franz, T. Fulmer, T. Gilovich, A. Grant, N. Lewis, S. Ratzan, D. Sable, and B. Staw. 2021. COVID-19 Vaccination Uptake Behavioral Science Task Force: Final Report—February 23, 2021. https://mgmt.wharton.upenn.edu/wp-content/uploads/2021/03/Covid-19_Vaccine-Uptake-Behavioral-Science_Task-Force_Report_Feb-23-2021.pdf (accessed February 5, 2023).
Bokemper, S. E., A. S. Gerber, S. B. Omer, and G. A. Huber. 2021a. Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021. Proceedings of the National Academy of Sciences 118(49):e2114762118.
Bokemper, S. E., G. A. Huber, A. S. Gerber, E. K. James, and S. B. Omer. 2021b. Timing of COVID-19 vaccine approval and endorsement by public figures. Vaccine 39(5):825-829.
Branswell, H. 2018. Who will answer the call in the next outbreak? Drug makers feel burned by string of vaccine pleas. STAT. https://www.statnews.com/2018/01/11/vaccines-drug-makers/ (accessed February 17, 2023).
Branswell, H. 2022. WHO, Uganda plan to test three candidate Ebola vaccines in outbreak. STAT. https://www.statnews.com/2022/11/16/who-uganda-plan-to-test-three-candidate-ebola-vaccines-in-outbreak/ (accessed February 18, 2023).
Bryon, J., H. Rita, N. Suchar. 2022. In Focus: MMWR Severe Monkeypox (MPX) Study. U.S. Department of Housing and Urban Development. https://www.hud.gov/sites/dfiles/CPD/documents/HOPWA-Listerv-MMWR-Severe-Monkeypox.pdf.
Burgess, D. J., J. Warren, S. Phelan, J. Dovidio, and M. van Ryn. 2010. Stereotype threat and health disparities: What medical educators and future physicians need to know. Journal of General Internal Medicine 25(2):169-177.
Callaway, E., H. Ledford, G. Viglione, T. Watson, and A. Witze. 2020. COVID and 2020: An extraordinary year for science. Nature 588(7839):550-552.
CDC (U.S. Centers for Disease Control and Prevention). 2022a. COVID Data Tracker. https://covid.cdc.gov/covid-data-tracker/#datatracker-home (accessed January 13, 2023).
CDC. 2022b. COVID-19 Vaccinations in the United States. https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total (accessed January 30, 2023).
CDC. 2022c. Demographic Trends of COVID-19 Cases and Deaths in the US Reported to CDC. https://covid.cdc.gov/covid-data-tracker/#demographics (accessed January 14, 2023).
CDC. 2022d. Mpox. https://www.cdc.gov/poxvirus/monkeypox/ (accessed February 12, 2023).
CEPI. 2022. Delivering Pandemic Vaccines in 100 Days. Oslo, Norway: CEPI.
Cheever, L. W. 2022. Monkeypox Guidance for Ryan White HIV/AIDS Program. U.S. Department of Health and Human Services. https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/monkeypox-guidance-dear-colleague.pdf (accessed September 16, 2023).
Chen, W.-H., J. Wei, R. T. Kundu, R. Adhikari, Z. Liu, J. Lee, L. Versteeg, C. Poveda, B. Keegan, M. J. Villar, A. C. de Araujo Leao, J. A. Rivera, P. M. Gillespie, J. Pollet, U. Strych, B. Zhan, P. J. Hotez, and M. E. Bottazzi. 2021. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochimica et Biophysica Acta (BBA)—General Subjects 1865(6):129893.
Chen, W. H., J. Pollet, U. Strych, J. Lee, Z. Liu, R. T. Kundu, L. Versteeg, M. J. Villar, R. Adhikari, J. Wei, C. Poveda, B. Keegan, A. O. Bailey, Y. L. Chen, P. M. Gillespie, J. T. Kimata, B. Zhan, P. J. Hotez, and M. E. Bottazzi. 2022. Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate. Protein Expression and Purification 190:106003.
Chow, M., and J. Birdwell. 2022. Confidence in Research: Researchers in the Spotlight. Washington DC: Economist Impact.
Cohen, J. 2022. Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis. In IAVI Report, edited by K. K. Abboud. New York, NY: International AIDS Vaccine Initiative.
Commission on a Global Health Risk Framework for the Future, and National Academy of Medicine. 2016. The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises. Washington, DC: National Academies Press.
COVAX. 2021. COVAX Global Supply Forecast. https://www.gavi.org/sites/default/files/covid/covax/COVAX-Supply-Forecast.pdf (accessed January 31, 2023).
Crane, M. A., K. M. Shermock, S. B. Omer, and J. A. Romley. 2021. Change in reported adherence to nonpharmaceutical interventions during the COVID-19 pandemic, April-November 2020. JAMA 325(9):883-885.
Curran, K. G., K. Eberly, O. O. Russell, R. E. Snyder, E. K. Phillips, E. C. Tang, P. J. Peters, M. A. Sanchez, L. Hsu, S. E. Cohen, E. K. Sey, S. Yin, C. Foo, W. Still, A. Mangla, B. x-Saafir-Callaway, L. Barrineau-Vejjajiva, C. Meza, E. Burkhardt, M. E. Smith, P. A. x-Murphy, N. K. Kelly, H. Spencer, I. Tabidze, M. Pacilli, C. A. Swain, K. Bogucki, C. DelBarba, D. T. Rajulu, A. Dailey, J. Ricaldi, L. A. Mena, D. Daskalakis, L. H. Bachmann, J. T. Brooks, and A. M. Oster. 2022. HIV and sexually transmitted infections among persons with monkeypox—eight U.S. jurisdictions, May 17–July 22, 2022. MMWR Morbidity and Mortality Weekly Report 71(36):1141-1147.
Data.CMS.gov. 2023. COVID-19 Nursing Home Data. https://data.cms.gov/covid-19/covid-19-nursing-home-data (accessed June 8, 2023).
Delphin-Rittmon, M. 2022. SAMHSA Grant Resources for Monkeypox-related Activities. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/sites/default/files/colleague-letter-monkeypox.pdf (accessed September 16, 2023).
DOD (U.S. Department of Defense). 2022. DoD Announces 2022 Defense Acquisition Workforce Award Winners. https://www.defense.gov/News/Releases/Release/Article/3240354/dod-announces-2022-defense-acquisition-workforce-award-winners/#:~:text=The%20Defense%20Acquisition%20Workforce%20is,continues%20to%20innovate%20-and%20modernize (accessed May 1, 2023).
Dolsten, J. 2019. US anti-vaxxers use Holocaust-era yellow stars to promote their agenda. The Times of Israel, April 6, 2019.
Dunlop, W. G. 2021. Tucker Carlson misrepresents government data on Covid-19 vaccines. AFP Fact Check, https://factcheck.afp.com/tucker-carlson-misrepresents-government-data-covid-19-vaccines (accessed February 7, 2023).
Earl, A., and N. A. Lewis Jr. 2019. Health in context: New perspectives on healthy thinking and healthy living. Journal of Experimental Social Psychology 81(3):1-4.
Emmerling, J., D. Furceri, F. L. Monteiro, P. Loungani, J. D. Ostry, P. Pizzuto, and M. Tavoni. 2021. Will the Economic Impact of COVID-19 Persist? Prognosis from 21st Century Pandemics. Washington, DC: International Monetary Fund.
Escandón, K., A. L. Rasmussen, Bogoch, II, E. J. Murray, K. Escandón, S. V. Popescu, and J. Kindrachuk. 2021. COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection. BMC Infectious Diseases 21(1):710.
ET Healthworld. 2021. Vaccine Is Completely Safe, Says Doctor Who Got First Jab in Gujarat. https://health.economictimes.indiatimes.com/news/industry/vaccine-is-completely-safe-says-doctor-who-got-first-jab-in-gujarat/80302615 (accessed February 3, 2022).
Faden, R., A. Cravioto, J. Hombach, D. C. Kaslow, S. Kochhar, H. Nohynek, A. Wilder-Smith, M. A. Crane, and S. B. Omer. 2022. Who to Vaccinate First? A Peek at Decision-Making in a Pandemic. New York: Nature Publishing Group.
Fang, F. C., C. A. Benson, C. Del Rio, K. M. Edwards, V. G. Fowler, D. N. Fredricks, A. P. Limaye, B. E. Murray, S. Naggie, P. G. Pappas, R. Patel, D. L. Paterson, D. A. Pegues, W. A. Petri, and R. T. Schooley. 2021. COVID-19-lessons learned and questions remaining. Clinical Infectious Diseases 72(12):2225-2240.
FDA (U.S. Food and Drug Administration). 2021. FDA News Release Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatement of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 (accessed June 7, 2023).
Feachem, N. S., K. Sanders, and F. Barker. 2021. The United States’ Response to COVID-19: A Case Study of the First Year. San Francisco, CA: University of California, San Francisco Institute for Global Health Sciences.
Gaba, C. 2021. COVID19 Case/Death Rates by County, Partisan Lean and Vaccination Rate. https://acasignups.net/21/12/02/weekly-update-covid19-casedeath-rates-county-partisan-lean-vaccination-rate (accessed January 26, 2023).
Gandhi, R. T., J. B. Lynch, and C. Del Rio. 2020. Mild or moderate Covid-19. New England Journal of Medicine 383(18):1757-1766.
Gavi, the Vaccine Alliance. 2022. Expanding Sustainable Vaccine Manufacturing in Africa: Priorities for Support. Geneva, Switzerland: Gavi, the Vaccine Alliance.
Godlee, F., J. Smith, and H. Marcovitch. 2011. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342.
Graham, B. S., and N. J. Sullivan. 2018. Emerging viral diseases from a vaccinology perspective: Preparing for the next pandemic. Nature Immunology 19(1):20-28.
Graham, B. S., J. R. Mascola, and A. S. Fauci. 2018. Novel vaccine technologies: Essential components of an adequate response to emerging viral diseases. JAMA 319(14):1431-1432.
Gupta, S. B., B.-A. Coller, and M. Feinberg. 2018. Unprecedented pace and partnerships: The story of and lessons learned from one Ebola vaccine program. Expert Review of Vaccines 17(10):913-923.
Haidt, J. 2022. Why the Past 10 Years of American Life Have Been Uniquely Stupid. The Atlantic, April 11, 2022.
Hammond, J., H. Leister-Tebbe, A. Gardner, P. Abreu, W. Bao, W. Wisemandle, M. Baniecki, V. M. Hendrick, B. Damle, A. Simon-Campos, R. Pypstra, and J. M. Rusnak. 2022. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. New England Journal of Medicine 386(15):1397-1408.
Hayman, B., and S. Pagliusi. 2020. Emerging vaccine manufacturers are innovating for the next decade. Vaccine: X 5:100066.
Heinrich, A. C., and S. B. Omer. 2021. The world isn’t ready for the next outbreak: The case for a pandemic trust fund. Foreign Affairs, September 6, 2021.
Heyerdahl, L. W., S. Dielen, T. Nguyen, C. Van Riet, T. Kattumana, C. Simas, N. Vandaele, A.-M. Vandamme, C. Vandermeulen, T. Giles-Vernick, H. Larson, K. P. Grietens, and C. Gryseels. 2022. Doubt at the core: Unspoken vaccine hesitancy among healthcare workers. The Lancet Regional Health—Europe 12:100289.
HHS (U.S Department of Health and Human Services). 2022. Biden Harris Administration Supports the World Health Organization Renaming of Monkeypox to mpox. https://www.hhs.gov/about/news/2022/11/28/biden-harris-administration-supports-the-world-health-organization-renaming-of-monkeypox-to-mpox.html (accessed February 12, 2023).
Hotez, P. J. 2021a. Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and Their Impact on Global Health and Development. New Jersey: John Wiley & Sons.
Hotez, P. J. 2021b. Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-Science: Maryland: Johns Hopkins University Press.
Hotez, P. J. 2021c. Vaccines Did Not Cause Rachel’s Autism: My Journey as a Vaccine Scientist, Pediatrician, and Autism Dad. Maryland: Johns Hopkins University Press.
Hotez, P. J. 2022a. The great Texas COVID tragedy. PLOS Global Public Health 2(10):e0001173.
Hotez, P. J. 2022b. SARS-CoV-2 variants offer a second chance to fix vaccine inequities. Nature Reviews Microbiology.
Hotez, P. J. 2022c. Will anti-vaccine activism in the USA reverse global goals? Nature Reviews Immunology 22(9):525-526.
Hotez, P. J., J. M. Bethony, D. J. Diemert, M. Pearson, and A. Loukas. 2010. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nature Reviews Microbiology 8(11):814-826.
Hotez, P. J., and M. E. Bottazzi. 2022. Whole inactivated virus and protein-based COVID-19 vaccines. Annual Review of Medicine 73:55-64.
Hotez, P. J., and M. T. Ferris. 2006. The antipoverty vaccines. Vaccine 24(31):5787-5799.
Humphreys, L., N. A. Lewis, Jr., K. Sender, and A. S. Won. 2021. Integrating qualitative methods and open science: Five principles for more trustworthy research. Journal of Communication 71(5):855-874.
Ingraham, C. 2015. California’s epidemic of vaccine denial, mapped. The Washington Post, January 27, 2015.
Institute of Medicine Committee on Assuring the Health of the Public in the 21st Century. 2002. The Future of the Public’s Health in the 21st Century. Washington, DC: National Academies Press.
Interlandi, J. 2020. Why we’re losing the battle with Covid-19. The New York Times Magazine, July 14, 2020.
International Pandemic Preparedness Partnership. 2021. 100 Days Mission to Respond to Future Pandemic Threats. London, UK.
Kington, R. S., S. Arnesen, W. S. Chou, S. J. Curry, D. Lazer, and A. M. Villarruel. 2021. Identifying credible sources of health information in social media: Principles and attributes. NAM Perspectives 2021.
Kriss, J. L., P. M. Boersma, E. Martin, K. Reed, J. Adjemian, N. Smith, R. J. Carter, K. R. Tan, A. Srinivasan, S. McGarvey, J. McGehee, D. Henderson, N. Aleshire, and A. V. Gundlapalli. 2022. Receipt of first and second doses of JYNNEOS vaccine for prevention of monkeypox—United States, May 22–October 10, 2022. MMWR Morbidity and Mortality Weekly Report 71(43):1374-1378.
Lee, J., Z. Liu, W.-H. Chen, J. Wei, R. Kundu, R. Adhikari, J. A. Rivera, P. M. Gillespie, U. Strych, B. Zhan, P. J. Hotez, and M. E. Bottazzi. 2021. Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1. Applied Microbiology and Biotechnology 105(10):4153-4165.
Lewis, N. A. 2021a. Can we achieve “equality” when we have different understandings of its meaning? How contexts and identities shape the pursuit of egalitarian goals. Psychological Inquiry 32(3):155-164.
Lewis, N. A. 2021b. What counts as good science? How the battle for methodological legitimacy affects public psychology. American Psychologist 76(8):1323-1333.
Lewis, N. A., and A. Earl. 2018. Seeing more and eating less: Effects of portion size granularity on the perception and regulation of food consumption. Journal of Personality and Social Psychology 114(5):786-803.
Lewis, N. A., D. G. Kougias, K. J. Takahashi, and A. Earl. 2021. The behavior of same-race others and its effects on Black patients’ attention to publicly presented HIV-prevention information. Health Communication 36(10):1252-1259.
Lewis, N. A., and D. Oyserman. 2016. Using identity-based motivation to improve the nation’s health without breaking the bank. Behavioral Science & Policy 2(2):24-38.
Lewis, N. A., and D. Sekaquaptewa. 2016. Beyond test performance: A broader view of stereotype threat. Current Opinion in Psychology 11:40-43.
Lucas, C., C. B. F. Vogels, I. Yildirim, J. E. Rothman, P. Lu, V. Monteiro, J. R. Gehlhausen, M. Campbell, J. Silva, A. Tabachnikova, M. A. Peña-Hernandez, M. C. Muenker, M. I. Breban, J. R. Fauver, S. Mohanty, J. Huang, C. Pearson, A. Muyombwe, R. Downing, J. Razeq, M. Petrone, I. Ott, A. Watkins, C. Kalinich, T. Alpert, A. Brito, R. Earnest, S. Murphy, C. Neal, E. Laszlo, A. Altajar, I. Tikhonova, C. Castaldi, S. Mane, K. Bilguvar, N. Kerantzas, D. Ferguson, W. Schulz, M. Landry, D. Peaper, A. C. Shaw, A. I. Ko, S. B. Omer, N. D. Grubaugh, A. Iwasaki, and S.-C.-G. S. I. Yale. 2021. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature 600(7889):523-529.
Lundberg, D. J., A. Cho, R. Raquib, E. O. Nsoesie, E. Wrigley-Field, and A. C. Stokes. 2022. Geographic and temporal patterns in Covid-19 mortality by race and ethnicity in the United States from March 2020 to February 2022. medRxiv.
Malik, A. A., S. M. McFadden, J. Elharake, and S. B. Omer. 2020. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 26:100495.
Mann, J. 1998. Presentation at XII International Conference on AIDS, June 28–July 3, 1998. Geneva, Switzerland.
McFadden, S. M., A. A. Malik, O. G. Aguolu, K. S. Willebrand, and S. B. Omer. 2020. Perceptions of the adult US population regarding the novel coronavirus outbreak. PloS one 15(4):e0231808.
Meltzer, M. I., C. Y. Atkins, S. Santibanez, B. Knust, B. W. Petersen, E. D. Ervin, S. T. Nichol, I. K. Damon, M. L. Washington, and Centers for Disease Control and Prevention (CDC). 2014. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015. MMWR Supplements 63(3):1-14.
Mergler, M. J., S. B. Omer, W. K. Y. Pan, A. M. Navar-Boggan, W. Orenstein, E. K. Marcuse, J. Taylor, M. P. DeHart, T. C. Carter, A. Damico, N. Halsey, and D. A. Salmon. 2013. Are recent medical graduates more skeptical of vaccines? Vaccines 1(2):154-166.
Mermin, J. 2022. Supporting Monkeypox Funding Update. Centers for Disease Control and Prevention. https://www.cdc.gov/nchhstp/dear_colleague/2022/supporting-monkeypox-funding.html (accessed September 16, 2023).
Miller, M. J., S. Cash-Goldwasser, G. E. Marx, C. A. Schrodt, A. Kimball, K. Padgett, R. S. Noe, D. W. McCormick, J. M. Wong, S. M. Labuda, B. F. Borah, I. Zulu, A. Asif, G. Kaur, J. M. McNicholl, A. Kourtis, A. Tadros, S. Reagan-Steiner, J. M. Ritter, Y. Yu, P. Yu, R. Clinton, C. Parker, E. S. Click, J. S. Salzer, A. M. McCollum, B. Petersen, F. S. Minhaj, E. Brown, M. P. Fischer, R. L. Atmar, A. R. DiNardo, Y. Xu, C. Brown, J. C. Goodman, A. Holloman, J. Gallardo, H. Siatecka, G. Huffman, J. Powell, P. Alapat, P. Sarkar, N. A. Hanania, O. Bruck, S. D. Brass, A. Mehta, A. W. Dretler, A. Feldpausch, J. Pavlick, H. Spencer, I. Ghinai, S. R. Black, L. N. Hernandez-Guarin, S. Y. Won, S. Shankaran, A. T. Simms, J. Alarcón, J. G. O’Shea, J. T. Brooks, J. McQuiston, M. A. Honein, S. M. O’Connor, K. Chatham-Stephens, K. O’Laughlin, A. K. Rao, E. Raizes, J. A. W. Gold, and S. B. Morris. 2022. Severe monkeypox in hospitalized patients—United States, August 10–October 10, 2022. MMWR Morbidity and Mortality Weekly Report 71(44):1412-1417.
Moon, S., D. Sridhar, M. A. Pate, A. K. Jha, C. Clinton, S. Delaunay, V. Edwin, M. Fallah, D. P. Fidler, and L. Garrett. 2015. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet 386(10009):2204-2221.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2018. Understanding the Economics of Microbial Threats: Proceedings of a workshop. Washington, DC: The National Academies Press.
NASEM. 2019. Exploring Lessons Learned from a Century of Outbreaks: Readiness for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press.
NASEM. 2020a. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press.
NASEM. 2020b. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: National Academies Press.
NASEM. 2021. The Critical Public Health Value of Vaccines: Tackling Issues of Access and Hesitancy: Proceedings of a Workshop. Washington, DC: The National Academies Press.
Omer, S. 2020. Is America ready for another outbreak? The New York Times, January 23, 2020.
Omer, S. 2021. Doctors and nurses are the key to the final vaccine push. The New York Times, June 24, 2021.
Omer, S. B., R. M. Benjamin, N. T. Brewer, A. M. Buttenheim, T. Callaghan, A. Caplan, R. M. Carpiano, C. Clinton, R. DiResta, J. A. Elharake, L. C. Flowers, A. P. Galvani, R. Lakshmanan, Y. A. Maldonado, S. M. McFadden, M. M. Mello, D. J. Opel, D. R. Reiss, D. A. Salmon, J. L. Schwartz, J. M. Sharfstein, and P. J. Hotez. 2021. Promoting COVID-19 vaccine acceptance: Recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet 398(10317):2186-2192.
Omer, S. B., and P. N. Malani. 2022. Booster vaccination to prevent COVID-19 in the era of Omicron: An effective part of a layered public health approach. JAMA 327(7):628-629.
Oppenheimer, L. 2006. The belief in a just world and subjective perceptions of society: a developmental perspective. Journal of Adolescence 29(4):655-669.
Our World in Data. 2022a. Daily COVID-19 Vaccine Doses Administered (Worldwide, Dec. 1, 2022). https://ourworldindata.org/grapher/daily-covid-19-vaccination-doses?tab=chart&time=earliest..2022-12-01&country=~OWID_WRL (accessed February 18, 2023).
Our World in Data. 2022b. Total COVID-19 Vaccine Doses Administered per 100 People, Dec 7, 2022. https://ourworldindata.org/grapher/covid-vaccination-doses-per-capita?tab=map&time=2022-12-07 (accessed February 18, 2023).
Pan American Health Organization. 2022. Catalyzing Ethical Research in Emergencies. Ethics Guidance, Lessons Learned from the COVID-19 Pandemic, and Pending Agenda. Washington, DC: Pan American Health Organization.
Parker, C. 2022. Organization leading Covax could end the vaccine-sharing initiative. The Washington Post, December 7, 2022.
Payne, A. B., L. C. Ray, M. M. Cole, M. Canning, K. Houck, H. J. Shah, J. L. Farrar, N. M. Lewis, A. Fothergill, E. B. White, L. R. Feldstein, L. E. Roper, F. Lee, J. L. Kriss, E. Sims, I. H. Spicknall, Y. Nakazawa, A. V. Gundlapalli, T. Shimabukuro, A. L. Cohen, M. A. Honein, J. Mermin, and D. C. Payne. 2022a. Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons—43 U.S. jurisdictions, July 31–October 1, 2022. MMWR Morbidity and Mortality Weekly Report 71(49):1560-1564.
Payne, A. B., L. C. Ray, K. J. Kugeler, A. Fothergill, E. B. White, M. Canning, J. L. Farrar, L. R. Feldstein, A. V. Gundlapalli, K. Houck, J. L. Kriss, N. M. Lewis, E. Sims, D. K. Smith, I. H. Spicknall, Y. Nakazawa, I. K. Damon, A. C. Cohn, and D. C. Payne. 2022b. Incidence of monkeypox among unvaccinated persons compared with persons receiving ≥1 JYNNEOS vaccine dose—32 U.S. jurisdictions, July 31–September 3, 2022. MMWR Morbidity and Mortality Weekly Report 71(40):1278-1282.
Peccia, J., A. Zulli, D. E. Brackney, N. D. Grubaugh, E. H. Kaplan, A. Casanovas-Massana, A. I. Ko, A. A. Malik, D. Wang, M. Wang, J. L. Warren, D. M. Weinberger, W. Arnold, and S. B. Omer. 2020. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nature Biotechnology 38(10):1164-1167.
Penner, L. A., N. Hagiwara, S. Eggly, S. L. Gaertner, T. L. Albrecht, and J. F. Dovidio. 2013. Racial healthcare disparities: A social psychological analysis. European Review of Social Psychology 24(1):70-122.
Pérez-Then, E., C. Lucas, V. S. Monteiro, M. Miric, V. Brache, L. Cochon, C. B. F. Vogels, A. A. Malik, E. De la Cruz, A. Jorge, M. De los Santos, P. Leon, M. I. Breban, K. Billig, I. Yildirim, C. Pearson, R. Downing, E. Gagnon, A. Muyombwe, J. Razeq, M. Campbell, A. I. Ko, S. B. Omer, N. D. Grubaugh, S. H. Vermund, and A. Iwasaki. 2022. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nature Medicine 28(3):481-485.
Petersen, W. 1995. Outbreak. Warner Bros. Pictures.
Pew Research Center. 2022. The Changing Political Geography of COVID-19 Over the Last Two Years. https://www.pewresearch.org/politics/2022/03/03/the-changing-political-geography-of-covid-19-over-the-last-two-years/ (accessed March 29, 2023).
Pinna, M., L. Picard, and C. Goessmann. 2022. Cable news and COVID-19 vaccine uptake. Scientific Reports 12(1):16804.
Piot, P. 2012. No Time To Lose: A Life In Pursuit of Deadly Viruses. New York: W.W. Norton & Company.
Plotkin, S. A., A. A. F. Mahmoud, and J. Farrar. 2015. Establishing a global vaccine-development fund. New England Journal of Medicine 373(4):297-300.
Polack, Fernando P., S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J. L. Perez, G. Pérez Marc, E. D. Moreira, C. Zerbini, R. Bailey, K. A. Swanson, S. Roychoudhury, K. Koury, P. Li, W. V. Kalina, D. Cooper, R. W. Frenck, L. L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. B. Tresnan, S. Mather, P. R. Dormitzer, U. Şahin, K. U. Jansen, and W. C. Gruber. 2020. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine 383(27):2603-2615. https://doi.org/10.1056/NEJMoa2034577.
PolitiFact. 2021. Fact-checking the claim that the COVID-19 vaccine is the “deadliest.” The Poynter Institute. December 10, 2021. https://www.youtube.com/watch?v=7AtahvsKQY0 (accessed July 17, 2023).
Pollet, J., W. H. Chen, L. Versteeg, B. Keegan, B. Zhan, J. Wei, Z. Liu, J. Lee, R. Kundu, R. Adhikari, C. Poveda, M. J. Villar, A. C. de Araujo Leao, J. A. Rivera, Z. Momin, P. M. Gillespie, J. T. Kimata, U. Strych, P. J. Hotez, and M. E. Bottazzi. 2021. SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. bioRxiv.
Pollet, J., U. Strych, W. H. Chen, L. Versteeg, B. Keegan, B. Zhan, J. Wei, Z. Liu, J. Lee, R. Kundu, R. Adhikari, C. Poveda, M. J. Villar, S. R. Thimmiraju, B. Lopez, P. M. Gillespie, S. Ronca, J. T. Kimata, M. Reers, V. Paradkar, P. Hotez, and M. E. Bottazzi. 2022. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern. bioRxiv.
Rachlin, A., M. C. Danovaro-Holliday, P. Murphy, S. V. Sodha, and A. S. Wallace. 2022. Routine vaccination coverage—worldwide, 2021. MMWR Morbidity and Mortality Weekly Report 71(44):1396-1400.
Rincon-Arevalo, H., M. Choi, A.-L. Stefanski, F. Halleck, U. Weber, F. Szelinski, B. Jahrsdörfer, H. Schrezenmeier, C. Ludwig, A. Sattler, K. Kotsch, A. Potekhin, Y. Chen, G. R. Burmester, K.-U. Eckardt, G. M. Guerra, P. Durek, F. Heinrich, M. Ferreira-Gomes, A. Radbruch, K. Budde, A. C. Lino, M.-F. Mashreghi, E. Schrezenmeier, and T. Dörner. 2021. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Science Immunology 6(60):eabj1031.
Rodriguez-Morales, A. J., V. Gallego, J. P. Escalera-Antezana, C. A. Méndez, L. I. Zambrano, C. Franco-Paredes, J. A. Suárez, H. D. Rodriguez-Enciso, G. J. Balbin-Ramon, E. Savio-Larriera, A. Risquez, and S. Cimerman. 2020. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Medicine and Infectious Disease 35(101613).
Romer, D., K. M. Winneg, P. E. Jamieson, C. Brensinger, and K. H. Jamieson. 2022. Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5–11-year-olds in the United States. Vaccine 40(45):6463-6470.
Rotesi, T., P. Pin, M. Cucciniello, A. A. Malik, E. E. Paintsil, S. E. Bokemper, K. Willebrand, G. A. Huber, A. Melegaro, and S. B. Omer. 2021. National interest may require distributing COVID-19 vaccines to other countries. Scientific Reports 11(1):18253.
Røttingen, J.-A., D. Gouglas, M. Feinberg, S. Plotkin, K. V. Raghavan, A. Witty, R. Draghia-Akli, P. Stoffels, and P. Piot. 2017. New vaccines against epidemic infectious diseases. New England Journal of Medicine 376(7):610-613.
Scherer, L.D., V. A. Shaffer, N. Patel, and B. J. Zikmund-Fisher. 2016. Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust?. Vaccine 34(21):2424-2429.
Schwarz, N. 2012. Feelings-as-information theory. In Handbook of Theories of Social Psychology. Vol. 1, edited by P. A. M. Van Lange, A. W. Kruglanski and E. T. Higgins. Thousand Oaks, CA: Sage. Pp. 289-308.
Scott, D. 2016. Millions in Ebola funding, a casualty of Zika virus, may not be replenished. STAT, https://www.statnews.com/2016/06/01/ebola-zika-virus-funding/ (accessed February 18, 2023).
Soderbergh, S. 2011. Contagion. Warner Bros. Pictures.
Solís Arce, J. S., S. S. Warren, N. F. Meriggi, A. Scacco, N. McMurry, M. Voors, G. Syunyaev, A. A. Malik, S. Aboutajdine, O. Adeojo, D. Anigo, A. Armand, S. Asad, M. Atyera, B. Augsburg, M. Awasthi, G. E. Ayesiga, A. Bancalari, M. Björkman Nyqvist, E. Borisova, C. M. Bosancianu, M. R. Cabra García, A. Cheema, E. Collins, F. Cuccaro, A. Z. Farooqi, T. Fatima, M. Fracchia, M. L. Galindo Soria, A. Guariso, A. Hasanain, S. Jaramillo, S. Kallon, A. Kamwesigye, A. Kharel, S. Kreps, M. Levine, R. Littman, M. Malik, G. Manirabaruta, J. L. H. Mfura, F. Momoh, A. Mucauque, I. Mussa, J. A. Nsabimana, I. Obara, M. J. Otálora, B. W. Ouédraogo, T. B. Pare, M. R. Platas, L. Polanco, J. A. Qureshi, M. Raheem, V. Ramakrishna, I. Rendrá, T. Shah, S. E. Shaked, J. N. Shapiro, J. Svensson, A. Tariq, A. M. T chibozo, H. A. Tiwana, B. Trivedi, C. Vernot, P. C. Vicente, L. B. Weissinger, B. Zafar, B. Zhang, D. Karlan, M. Callen, M. Teachout, M. Humphreys, A. M. Mobarak, and S. B. Omer. 2021. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nature Medicine 27(8):1385-1394.
Song, H., and N. Schwarz. 2008. If it’s hard to read, it’s hard to do: Processing fluency affects effort prediction and motivation. Psychological Science 19(10):986-988.
Stone, J. R. 2016. Racism and bioethics: Experiences and reflections. The American Journal of Bioethics 16(4):13-15.
Texas Department of State Health Services. 2022. Annual Report of Immunization Status of Students: 2021-2022 School Year. https://www.dshs.texas.gov/sites/default/files/immunize/coverage/docs/2021-2022-Results-of-Annual-Report-of-Immunization-Status.pdf (accessed March 29, 2023).
The Economic Times. 2020. Gujarat forms task force to oversee COVID-19 vaccine drive. The Economic Times, December 28, 2020.
The New York Times. 2022. Coronavirus in the U.S.: Latest Map and Case Count. https://www.nytimes.com/interactive/2021/us/covid-cases.html (accessed January, 14, 2023).
Thuluva, S., V. Paradkar, S. Gunneri, V. Yerroju, R. R. Mogulla, P. V. Suneetha, K. Turaga, M. Kyasani, S. K. Manoharan, S. Adabala, A. Sri Javvadi, G. Medigeshi, J. Singh, H. Shaman, A. Binayke, A. Zaheer, A. Awasthi, M. Narang, P. Nanjappa, N. Mahantshetti, B. Swarup Garg, and A. K. Pandey. 2022a. Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study. Vaccine 40(49):7130-7140.
Thuluva, S., V. Paradkar, S. R. Gunneri, V. Yerroju, R. Mogulla, K. Turaga, M. Kyasani, S. K. Manoharan, G. Medigeshi, J. Singh, H. Shaman, C. Singh, and V. Rao A. 2022b. Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials. eBioMedicine 83:104217.
Thuluva, S., V. Paradkar, K. Turaga, S. Gunneri, V. Yerroju, R. Mogulla, P. V. Suneetha, M. Kyasani, S. K. Manoharan, S. Adabala, A. S. Javvadi, G. Medigeshi, J. Singh, H. Shaman, A. Binayke, A. Zaheer, A. Awasthi, C. Singh, A. Venkateshwar Rao, I. Basu, K. Akash Ashok Kumar, and A. K. Pandey. 2022c. Immunogenic superiority and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial. medRxiv:2022.2003.2020.22271891.
Topol, E. 2022. It’s the Virus, Stupid. https://erictopol.substack.com/p/its-the-virus-stupid?utm_medium=email (accessed January 14, 2023).
Topol, E. J., and A. Iwasaki. 2022. Operation Nasal Vaccine-Lightning speed to counter COVID-19. Science Immunology 7(74):eadd9947.
UNICEF. 2020. Vaccine Misinformation Management Field Guide. New York: United Nations Children’s Fund.
Uttekar, S., N. MacDonald, W. A. Orenstein, M. Danchin, V. Blaser, A. Thomson, L. Menning, L. Shimp, B. Rath, R. Limaye, D. Esangbedo, S. Abeyesekera, S. Malue Nielsen, S. Mackay, T. Purnat, K. Duraisamy, V. Karthickeyan, A. Siddique, and N. Thacker. 2023. Empowering Health Workers to Build Public Trust in Vaccination: Experience from the International Pediatric Association’s Online Vaccine Trust Course, 2020–2021. Vaccine 41(2):435-443.
Wellcome Trust, and Center for Infectious Disease Research and Policy. 2015. Recommendations for Accelerating the Development of Ebola Vaccines. Minneapolis, MN: University of Minnesota.
White House. 2021. American Pandemic Preparedness: Transforming Our Capabilities. Washington, DC: White House.
White House. 2022. National Biodefense Strategy and Implementation Plan. Washington, DC: White House.
White House Steering Committee for Pandemic Innovation. 2022. First Annual Report on Progress Towards Implementation of the American Pandemic Preparedness Plan. Washington, DC: White House.
WHO (World Health Organization). 2015a. Report of the Ebola Interim Assessment Panel. Geneva, Switzerland: World Health Organization.
WHO. 2015b. Vaccine Hesitancy: A Growing Challenge for Immunization Programmes. https://www.who.int/en/news-room/detail/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes (accessed February 3, 2023).
WHO. 2015c. 2014 Ebola outbreak in West Africa Graph 1: Cumulative reported cases of Ebola virus disease in Guinea, Liberia, and Sierra Leone, March 25, 2014—January 18, 2015, by date of WHO Situation Report, n=21689. https://stacks.cdc.gov/view/cdc/27150 (accessed June 12, 2023)
WHO. 2019. Ten Threats to Global Health in 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed February 3, 2023).
WHO. 2020a. Behavioural Considerations for Acceptance and Uptake of COVID-19 Vaccines. Geneva: World Health Organization.
WHO. 2020b. Immunization Agenda 2030. Geneva, Switzerland: World Health Organization.
WHO. 2020c. WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines in the Context of Limited Supply: An Approach to Inform Planning and Subsequent Recommendations Based on Epidemiological Setting and Vaccine Supply Scenarios. Geneva, Switzerland: World Health Organization.
WHO. 2021. Implementing the Immunization Agenda 2030. Geneva, Switzerland: World Health Organization.
WHO. 2022a. Immunization Coverage. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage (accessed February 7, 2023).
WHO. 2022b. WHO Recommends New Name for Monkeypox Disease. https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease (accessed February 12, 2023).
Winters, M., A. A. Malik, and S. B. Omer. 2022. Attitudes towards Monkeypox vaccination and predictors of vaccination intentions among the US general public. PloS one 17(12):e0278622.
Wyllie, A. L., J. Fournier, A. Casanovas-Massana, M. Campbell, M. Tokuyama, P. Vijayakumar, J. L. Warren, B. Geng, M. C. Muenker, A. J. Moore, C. B. F. Vogels, M. E. Petrone, I. M. Ott, P. Lu, A. Venkataraman, A. Lu-Culligan, J. Klein, R. Earnest, M. Simonov, R. Datta, R. Handoko, N. Naushad, L. R. Sewanan, J. Valdez, E. B. White, S. Lapidus, C. C. Kalinich, X. Jiang, D. J. Kim, E. Kudo, M. Linehan, T. Mao, M. Moriyama, J. E. Oh, A. Park, J. Silva, E. Song, T. Takahashi, M. Taura, O. E. Weizman, P. Wong, Y. Yang, S. Bermejo, C. D. Odio, S. B. Omer, C. S. Dela Cruz, S. Farhadian, R. A. Martinello, A. Iwasaki, N. D. Grubaugh, and A. I. Ko. 2020. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. New England Journal of Medicine 383(13):1283-1286.
Yale Institute for Global Health. 2022. iVaccinate: Behavioral Insights for Vaccination. New Haven, CT: Yale University.
Yale Institute for Global Health, and UNICEF. 2020. Vaccine Messaging Guide. New York: Yale Institue for Global Health; United Nations Children’s Fund.
Yan, Y., A. A. Malik, J. Bayham, E. P. Fenichel, C. Couzens, and S. B. Omer. 2021. Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic. Proceedings of the National Academy of Sciences 118(16):e2008814118.
Yourish, K., K. K. R. Lai, D. Ivory, and M. Smith. 2020. One-third of all U.S. coronavirus deaths are nursing home residents or workers. The New York Times, May 11.
This page intentionally left blank.
